The Netherlands Builds the World’s First Cultivated Meat Farm: Real Beef, Grown in a Bioreactor

In a quiet but significant development for the future of food, the Netherlands is pioneering what could become the world’s first integrated cultivated meat farm. Announced in 2025 through the CRAFT Consortium (led by RespectFarms in partnership with Mosa Meat, Aleph Farms, Multus, Kipster, Royal Kuijpers, and Wageningen University & Research), the project aims to embed cell-cultured meat production directly onto traditional farms.
This isn’t another plant-based “meat alternative.” It’s actual animal muscle tissue grown from cells — real beef, produced without slaughtering animals at scale.
How Cultivated Meat Works

Inside the bioreactor, the cells are bathed in a nutrient-rich medium containing glucose, amino acids, vitamins, minerals, and growth factors.
The cells multiply and differentiate, forming structured muscle tissue that is biologically identical to conventional beef. The result can be harvested, processed, and turned into ground beef, burgers, or (eventually) whole cuts.
Mosa Meat, one of the pioneers in the space, has been refining this since co-founder Mark Post unveiled the world’s first cultivated beef burger in 2013 (which famously cost around $330,000 to produce at the time). Today, the company and its peers have driven costs down dramatically through better cell lines, serum-free media, and scaled bioprocessing.
From Lab to Farm: The Dutch Experiment

The CRAFT project, co-funded by EIT Food, is now designing and building this pilot farm. It emphasizes hybrid models — combining cultivated meat with conventional farming practices — to create resilient, lower-impact food systems. Proponents highlight major potential reductions in land use, water consumption, and overall environmental footprint compared to traditional livestock farming.
This builds on earlier Dutch innovation: RespectFarms co-founder Ira van Eelen is the daughter of Willem van Eelen, who filed some of the earliest patents on cultivated meat technology in the 1990s.
Why This Matters: Beyond the Plant-Based Hype Cycle

That category faced real challenges with cost, sensory appeal, and consumer expectations.
Cultivated (cell-based) meat is fundamentally different: it is meat at the cellular level, just grown outside the animal. Proponents argue it can deliver the authentic taste, texture, and nutrition of conventional beef while sidestepping many of the ethical, environmental, and scalability issues of industrial animal agriculture.
Major Hurdles Remain
Two big barriers stand in the way of widespread adoption:
1. Economics
Ten years ago, producing a kilogram of cultivated meat could cost over a million dollars. Through advances in media formulation, cell efficiency, and bioreactor design, costs have plummeted — in some cases by 99.999% or more for certain components. Mosa Meat and others now talk about reaching price points suitable for restaurant menus.
The Dutch farm project is explicitly designed to test and optimize real-world economics at farm scale. However, reaching supermarket parity with conventional meat will likely require further breakthroughs in scaling and efficiency.

Cultivated meat faces a patchwork of rules globally. In the EU, it falls under the Novel Foods regulation, requiring rigorous safety assessments by EFSA. Progress is slow, and some member states have introduced or considered restrictions, often influenced by agricultural lobbying interests.
In the United States, several products (mostly chicken) have received federal approval, but several states have enacted or proposed bans on sales. Other regions like Singapore have been more permissive. Regulatory uncertainty remains a major drag on investment and commercialization.
Addressing the Myths
One common concern is safety — particularly claims that cultivated meat could increase cancer risk because cells in bioreactors might have their natural division limits (“Hayflick limit”) removed. Scientists and organizations like the Good Food Institute emphasize that this is a misunderstanding. The cell lines used are carefully controlled, non-tumorigenic, and rigorously tested. Regulatory bodies focus on comprehensive safety data rather than theoretical risks.
Also read:
Building the “Pipeline” for AI: Why Most Corporate Pilots Fail — and Why China Is Betting Everything on Diffusion
YouTube vs Television: 1-0. How Brazil, the World’s Most Football-Obsessed Nation, Is Watching the 2026 World Cup
India’s IT Outsourcing Sector: The Early Warning System for AI’s Dual Impact on Global Tech Jobs
Netflix Urges France to Ease Up on Stringent Local Content Investment Rules
A Long Game with Real Potential
Cultivated meat is unlikely to replace conventional meat overnight. The technology is still maturing, costs need to fall further, and consumer acceptance plus clear labeling will be essential.

The Netherlands project represents a pragmatic next step: moving from lab demonstrations to real-world integration on farms.
It tests whether this technology can work with agriculture rather than purely replacing it.
Whether this becomes a meaningful part of the food system in the 2030s or remains a niche premium product will depend on continued scientific progress, smart regulation, and economics. But after years of hype cycles and setbacks in the broader alternative protein space, the quiet, methodical work happening in Dutch bioreactors and on Dutch farms suggests the story of “meat from a lab” is far from over — it may just be entering a more realistic, farm-integrated chapter.
Subscribe to our newsletter
Get the latest Web3, AI, and crypto news delivered straight to your inbox.